Chagas disease: A role for autoimmunity?

Trends in Parasitology

Volumn 19, Issue 10, 2003, Pages 447-451

  Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIINFECTIVE AGENT; ITRACONAZOLE;

AUTOIMMUNITY; CHAGAS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; HEART DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOLECULAR EVOLUTION; NONHUMAN; PARASITOSIS; PATHOLOGY; QUANTITATIVE ANALYSIS; REVIEW; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 1142291085     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2003.08.008     Document Type: Article

References (43)

1. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 81:2002;123-132.
2. Leon J.S., Engman D.M. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31:2001;555-561.
3. Soares M.B., et al. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An. Acad. Bras. Cienc. 73:2001;547-559.
4. Girones N., Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol. 19:2003;19-22.
5. Takle G.B., Hudson L. Autoimmunity and Chagas' disease. Curr. Top. Microbiol. Immunol. 145:1989;79-92.
6. Brener Z. Immunity to Trypanosoma cruzi. Adv. Parasitol. 18:1980;247-292.
7. Rose N.R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today. 14:1993;426-430.
8. Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2:2001;797-801.
9. Caliari M.V., et al. Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy. Rev. Inst. Med. Trop. Sao Paulo. 44:2002;273-278.
10. Palomino S.A., et al. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann. Trop. Med. Parasitol. 94:2000;571-579.
11. Tarleton R.L. Tyler K.M., Miles M.A. World Class Parasites: American Trypanosomiasis. World Class Parasites: American Trypanosomiasis. Vol. 7:2003;107-116 Kluwer Academic Publishers.
12. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:2001;550-554.
13. Guarner J., et al. Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am. J. Trop. Med. Hyg. 65:2001;152-158.
14. Monteon-Padilla V., et al. Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Arch. Med. Res. 32:2001;39-43.
15. Bustamante J.M., et al. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Clin. Sci. (Lond.). 104:2003;415-420.
16. Bustamante J.M., et al. Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage. Int. J. Parasitol. 32:2002;889-896.
17. Storino R., et al. Chagasic cardiopathy in endemic area versus sporadically infected patients. Rev. Saude Publica. 36:2002;755-758.
18. Guerra F. American trypanosomiasis. An historical and a human lesson. J. Trop. Med. Hyg. 73:1970;105-118.
19. Laguens R.P., et al. Immunopathologic and morphologic studies of skeletal muscle in Chagas' disease. Am. J. Pathol. 80:1975;153-162.
20. Sanz O.P., et al. An electrophysiological investigation of skeletal muscle in human chronic Chagas' disease. Arq. Neuropsiquiatr. 36:1978;319-326.
21. Buckner F.S., et al. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect. Immun. 67:1999;403-409.
22. Rodrigues D., et al. Pathologic findings in the adrenal glands of autopsied patients with acquired immunodeficiency syndrome. Pathol. Res. Pract. 198:2002;25-30.
23. Teixeira Vde P., et al. Correlation between adrenal central vein parasitism and heart fibrosis in chronic chagasic myocarditis. Am. J. Trop. Med. Hyg. 56:1997;177-180.
24. La Forgia M.P., et al. Cutaneous manifestation of reactivation of Chagas disease in a renal transplant patient: long-term follow-up. Arch. Dermatol. 139:2003;104-105.
25. Silva N., et al. Trypanosoma cruzi meningoencephalitis in HIV-infected patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20:1999;342-349.
26. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 180:1999;480-486.
27. Jones E.M., et al. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:1993;348-357.
28. Vago A.R., et al. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet. 348:1996;891-892.
29. Viotti R., et al. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 127:1994;151-162.
30. Apt W., et al. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up. Ann. Trop. Med. Parasitol. 97:2003;23-29.
31. Coura J.R., de Castro S.L. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz. 97:2002;3-24.
32. Braga M.S., et al. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev. Inst. Med. Trop. Sao Paulo. 42:2000;157-161.
33. Lauria-Pires L., et al. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am. J. Trop. Med. Hyg. 63:2000;111-118.
34. Tarleton R.L., et al. Autoimmune rejection of neonatal heart transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3932-3937.
35. Girones N., et al. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 107:2001;985-993.
36. Leon J.S., et al. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect. Immun. 69:2001;5643-5649.
37. Pontes-de-Carvalho L., et al. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J. Autoimmun. 18:2002;131-138.
38. Cunha-Neto E., et al. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3541-3545.
39. Reina-San-Mart N.B., et al. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol. Today. 16:2000;62-67.
40. Ferreira M.S., Borges A.S. Some aspects of protozoan infections in immunocompromised patients - a review. Mem. Inst. Oswaldo Cruz. 97:2002;443-457.
41. Garg N., Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70:2002;5547-5555.
42. Arribada A., et al. A four year follow up survey of chagasic cardiopathy in Chile. Bull. Pan Am. Health Organ. 20:1986;254-266.
43. Olivieri B.P., et al. Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8(+) T-cell expansion and promotes resistance to reinfection. Antimicrob. Agents Chemother. 46:2002;3790-3796.